Taipei, May 7 (CNA) The Taiwan Food and Drug Administration (TFDA) on Tuesday announced a recall of over 1.78 million tablets of an antipsychotic medication due to cross-contamination from another pharmaceutical ingredient during the manufacturing pr
Related
Share this page
Guest Posts by Easy Branches